8 March 2013
Organised by:
SCI's Biotechnology Group in conjunction with the University of Westminster
University of Westminster
This event is no longer available for registration.
Inflammation is a formidable ally in the constant battle against infection, cancer and tissue injury. It’s a primordial response that protects against injury and restores damaged tissue to its normal physiological functioning.
In fact, our wellbeing and survival depends upon its efficiency and carefully-balanced control. In general, the innate inflammatory response initiates within minutes and, if all is well, resolves within hours. In contrast, chronic inflammation persists for weeks, months or even years. It is this breakdown in the control of immune responses leading to a persistent inflammation-driven disease state that will be the focus of this presentation.
Specifically, Gilroy will recall the crucial checkpoints necessary for mounting a limited yet effective inflammatory response. In particular, he will focus on the role of lipid mediators in this setting and discuss how endogenous eicosanoids are critical for immune suppression and resolution on the one hand, but in the context of chronic inflammatory diseases assume a different more detrimental role leading to immune suppression and substantial susceptibility to infection and morality.
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
University of Westminster
University of Westminster, School of Life Sciences, 115 New Cavendish Street London W1W 6UW
For a Map click here.
SCI Comms Team
Email: Communications@soci.org
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
Professor Derek Gilroy
Metabolism and Experimental Therapeutics, Division of Medicine, Faculty of Medical Sciences, University College London.